Margin and profit improvements drove EBITA above 12% in both segments, with 5% revenue growth and strong cash flow. Acquisition of Edge Medical and a robust M&A pipeline position the group for further growth.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
